MA
MRK icon

Maxele Advisors’s Merck MRK Stock Holding History

Maxele Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$677K Buy
+5,271
New +$617K 0.47% 51
2025
Q4 		$557K Buy
5,296
+121
+2% +$11.4K 0.45% 53
2025
Q3 		$434K Buy
5,175
+9
+0.2% +$741 0.37% 60
2025
Q2 		$409K Sell
5,166
-370
-7% -$29.4K 0.36% 63
2025
Q1 		$497K Sell
5,536
-208
-4% -$19.4K 0.48% 51
2024
Q4 		$571K Buy
+5,744
New +$592K 0.55% 50
2022
Q3 		$412K Buy
4,781
+15
+0.3% +$1.34K 0.69% 44
2022
Q2 		$435K Sell
4,766
-215
-4% -$19.1K 0.68% 45
2022
Q1 		$409K Buy
4,981
+1
+0% +$79 0.51% 50
2021
Q4 		$382K Buy
+4,980
New +$397K 0.44% 61

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Maxele Advisors's MRK Position: Q2 2026 in Review

Maxele Advisors opened a new position in Merck (MRK) in Q2 2026: 5,271 shares worth $677K. The stake represents 0.47% of the portfolio and ranks #51 among its holdings. This is a return to the name: Maxele Advisors previously reported a position in MRK as recently as Q4 2025.

Maxele Advisors first reported a position in MRK in Q4 2021 and has held it in 10 quarters since. 3,829 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Maxele Advisors held 5,271 shares of Merck worth $677K as of Q2 2026.
  • Merck was a new Maxele Advisors position in Q2 2026.
  • Merck made up 0.47% of Maxele Advisors's portfolio in Q2 2026, its #51 holding.
  • Maxele Advisors first reported a position in Merck in Q4 2021 and has held it in 10 quarters since.
  • 3,829 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Maxele Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.